Anaptysbio (ANAB) Retained Earnings (2016 - 2026)

Anaptysbio (ANAB) has 11 years of Retained Earnings data on file, last reported at -$146000.0 in Q1 2026.

• Quarterly Retained Earnings rose 99.98% year-over-year to -$146000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$146000.0 (up 99.98% YoY) and the FY2025 annual result came in at -$24000.0, up 100.0% from the prior year.
• Retained Earnings fell to -$146000.0 in Q1 2026, from -$24000.0 in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $715.0 million in Q2 2024 to a low of -$822.2 million in Q3 2025.
• A 5-year average of -$52.2 million and a median of -$2.4 million in 2023 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2022 — Retained Earnings surged 353931.0% — and 2024, when it tumbled 31284.81%.
• Tracing ANAB's Retained Earnings over 5 years: stood at -$5.2 million in 2022, then soared by 13500.1% to $703.0 million in 2023, then sank by 208.02% to -$759.3 million in 2024, then jumped by 100.0% to -$24000.0 in 2025, then tumbled by 508.33% to -$146000.0 in 2026.
• The last three Retained Earnings figures came in at -$146000.0 (Q1 2026), -$24000.0 (Q4 2025), and -$822.2 million (Q3 2025), per Business Quant data.